Comparing targeted plus standard biopsies for prostate cancer diagnosis
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether adding a targeted biopsy to a standard sextant biopsy improves the detection of prostate cancer. It is for men aged 45 to 85 who have a suspicious spot on an MRI of their prostate and have not had a biopsy before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 85 years old.
- You have never had a prostate biopsy before.
- You have a single suspicious spot on your prostate MRI, scored PI-RADS 3 or higher.
- You meet standard guidelines for needing a biopsy, such as a high PSA level or suspicious exam findings.
- Your MRI and biopsy are done within one month of each other.
- You have not had any prior prostate cancer treatments like radiation, chemotherapy, or hormone therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
This study aims to find the best way to take tissue samples (biopsies) from the prostate when MRI shows more than one suspicious spot. It will help doctors know exactly where to biopsy to reduce false negatives and avoid missing cancer.
This trial is testing a new way to do prostate biopsies by combining MRI findings with a targeted biopsy on the same side as the suspicious area. It is for men who have not had a biopsy before and have a moderately high PSA level.
This study checks whether a faster prostate MRI and image-matching (image-fusion) can better find suspicious spots so doctors can target a biopsy. If you have concerning prostate exam results or PSA blood test results, you may get an MRI and, if something looks suspicious, a biopsy using MRI images.
This trial tests whether repeat MRI scans can help monitor suspicious prostate areas and avoid unnecessary biopsies. It aims to improve detection of significant prostate cancer while reducing invasive procedures.
This study compares two ways of doing prostate biopsies (sampling tissue from the prostate) to see if one is better. It is for men who have a suspicious MRI finding on one side of the prostate and have not had a biopsy before. Participation may help determine which method is more accurate and could influence future care.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.